Qingxin kaiqiao fang ameliorates memory impairment and inhibits apoptosis in APP/PS1 double transgenic mice through the MAPK pathway

BACKGROUND: Qingxin kaiqiao fang (QKF) has been found to treat Alzheimer’s disease (AD) through apoptosis inhibition. The mitogen-activated protein kinase (MAPK) pathway is closely related to apoptosis in the course of AD. This study aimed to investigate whether QKF-induced apoptosis depression is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shiyu, Lin, Jianwei, Wang, Tianqi, Shen, Yan, Li, Yan, Yang, Wenyu, Zhou, Kailiang, Hu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350643/
https://www.ncbi.nlm.nih.gov/pubmed/30774310
http://dx.doi.org/10.2147/DDDT.S188505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350643/
https://www.ncbi.nlm.nih.gov/pubmed/30774310
http://dx.doi.org/10.2147/DDDT.S188505

Ejemplares similares